Expression of hepatitis A virus precursor protein P3 in vivo and in vitro: polyprotein processing of the 3CD cleavage site.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 8291234)

Published in Virology on February 01, 1994

Authors

M Tesar1, I Pak, X Y Jia, O C Richards, D F Summers, E Ehrenfeld

Author Affiliations

1: Department of Molecular Biology and Biochemistry, University of California, Irvine 92717.

Articles by these authors

Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 11.84

Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24

Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54

Protein synthesis in vesicular stomatitis virus-infected HeLa cells. Virology (1970) 5.14

Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells. Virology (1970) 4.85

Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol (1976) 4.65

Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet (1999) 3.80

Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61

Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52

Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50

Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47

The decrease in size and synthetic activity of poliovirus polysomes late in the infectious cycle. Virology (1967) 3.41

Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40

Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28

Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12

Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99

Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82

Determination of the gene sequence of poliovirus with pactamycin. Proc Natl Acad Sci U S A (1971) 2.80

Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79

Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58

In vitro assembly of poliovirus-related particles. Virology (1968) 2.55

Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36

Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32

Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31

Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30

An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29

Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 2.29

Purification and properties of HeLa cell plasma membranes. J Biol Chem (1971) 2.29

Oligomeric structures of poliovirus polymerase are important for function. EMBO J (2001) 2.27

Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26

Evidence for differences in size and composition of the poliovirus-specific polypeptides in infected HeLa cells. Virology (1968) 2.23

Characterization of ribonuclease-resistant RNA from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 2.22

Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19

Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13

Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13

Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10

Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07

Glycosylation of vesicular stomatitis virus glycoprotein in virus-infected HeLa cells. J Virol (1976) 2.06

Inhibition of cleavage of large poliovirus-specific precursor proteins in infected HeLa cells by inhibitors of proteolytic enzymes. J Virol (1972) 2.06

Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05

Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02

Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00

Evidence for ambiguity in the posttranslational cleavage of poliovirus proteins. Virology (1970) 1.93

Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection. Virology (1977) 1.92

Influenza A virus RNA polymerase subunit PB2 is the endonuclease which cleaves host cell mRNA and functions only as the trimeric enzyme. Virology (1995) 1.92

Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91

In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90

Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87

Th size and shape of bacteria by light scattering measurements. Biochim Biophys Acta (1968) 1.85

In vitro protein synthetic activity of membrane-bound poliovirus polyribosomes. Virology (1971) 1.84

Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79

Poliovirus RNA replication. Curr Top Microbiol Immunol (1990) 1.78

The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology (1996) 1.75

Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75

The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73

Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol (1971) 1.72

Genetic and physiological analysis of conjugation in Streptococcus faecalis. J Bacteriol (1982) 1.72

Constitution and function of polyribosomes of poliovirus-infected HeLa cells. Virology (1965) 1.65

Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60

Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58

Circular chloroplast DNA from Euglena gracilis. Proc Natl Acad Sci U S A (1971) 1.57

Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus. J Virol (1976) 1.57

Comparison of replication complexes synthesizing poliovirus RNA. Virology (1981) 1.55

The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55

Preparative elution of proteins blotted to Immobilon membranes. Anal Biochem (1988) 1.53

Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52

RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51

Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50

Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol (2001) 1.50

Purification, characterization, and comparison of poliovirus RNA polymerase from native and recombinant sources. J Biol Chem (1991) 1.49

Isolation of a transcriptionally active chromosome from chloroplasts of Euglena gracilis. Biochemistry (1976) 1.49

Gastric cancer and Helicobacter pylori infection. Br J Surg (1993) 1.48

Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J Virol (1989) 1.48

Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex. Proc Natl Acad Sci U S A (1985) 1.47

Identification of the hepatitis A virus internal ribosome entry site: in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region. Virology (1993) 1.47

Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45

Maturation pathway for ribosomal RNA in the Hela cell nucleolus. Nat New Biol (1972) 1.44

Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage. J Virol (1987) 1.41

Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol (1995) 1.40

Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus. J Virol (1976) 1.40

Effect of poliovirus double-stranded RNA on viral and host-cell protein synthesis. Proc Natl Acad Sci U S A (1974) 1.39

Polyadenylation of vesicular stomatitis virus mRNA. J Virol (1974) 1.39

Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells. J Virol (1982) 1.38

Capsid protein precursor is one of two initiated products of translation of poliovirus RNA in vitro. J Virol (1979) 1.37

Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37

In vitro protein-synthesizing activity of vesicular stomatitis virus-infected cell extracts. J Virol (1973) 1.37

Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells. J Virol (1972) 1.36

trans rescue of a mutant poliovirus RNA polymerase function. J Virol (1991) 1.35